US Stem Cell Clinic LLC, of Weston, Florida, and US Stem Cell Inc., of Sunrise, Florida, and their Chief Scientific Officer Kristin Comella, Ph.D. have adulterated and misbranded a stem cell drug product made from a patient’s adipose tissue, U.S. District Judge Ursula Ungaro of the Southern District of Florida declared in a summary judgment against the defendants.On behalf of FDA, The U.S. Department of Justice filed for a permanent injunction against the defendants in May 2018, after several attempts to provide the clinic and the individual defendants the opportunity to work with the agency to come into compliance with FDA regulations and protect patients from harm.